Considering vitamin D could modulate the innate and adaptive immune responses through the vitamin D receptor expressed on immune cells (B cells, T cells, and antigen-presenting cells) (36), vitamin D may have clinical relevance as adjuvant therapy in the management of MM. Here, VDR is linked to Miyoshi myopathy.